Mecasin treatment in patients with amyotrophic lateral sclerosis: study protocol for a randomized controlled trial
DiscussionThis trial will aim to identify the optimal dosage of Mecasin. Additionally, it will test the efficacy and safety of Mecasin in conjunction with standard treatment, riluzole, for alleviating the functional decline in patients with ALS.Trial registrationKorean National Clinical Trial Registry CRIS;KCT0001984. Registered on 28 July 2016.
Source: Trials - Category: Research Source Type: clinical trials
More News: ALS | Brain | Clinical Trials | Depression | Food and Drug Administration (FDA) | Hospitals | Investigational New Drugs | Neurology | Pain | Pulmonary Function Testing | Research | Study